Florida is launching a new initiative to tackle the growing problem of newborns exposed to prescription drugs, The Miami Herald reports.
Category results for "Prescription Drugs"
The Chairman of the House Appropriations Committee, Hal Rogers, on Monday called on Urban Outfitters to stop selling products designed to look like prescription pill bottles, the Associated Press reports.
The Neurological Center for Pain’s Chronic Pain Rehabilitation Program at the Cleveland Clinic has created a Chemical Education Track designed specifically for patients with chronic non-cancer pain who also have a therapeutic opioid addiction. Initial results are promising.
Former President Bill Clinton this week pledged his foundation will work with the New York Police Department and other partners to address prescription drug abuse, with a focus on college students.
More than a dozen drug companies are working on abuse-resistant painkillers, in the wake of the Food and Drug Administration’s decision last month not to approve any generic versions of the original form of OxyContin.
Fifty percent more pills were collected during the latest National Prescription Drug Take-Back Day, compared with the previous event in 2012, the Drug Enforcement Administration announced.
An analysis of college students’ Twitter use finds mentions of the attention deficit hyperactivity disorder drug Adderall spikes during finals. Tweets about the drug are most common among students in the northeast and south.
Georgia Governor Nathan Deal has signed a law that requires pain clinics to be licensed by the state medical board, and new clinics to be owned by physicians. The measure is designed to reduce prescription drug abuse, according to The Wall Street Journal.
The key ingredient in sleep medications such as Ambien has been linked to a 220 percent jump in emergency room visits between 2005 and 2010, according to a new government report.
The Food and Drug Administration this week asked for more information on an implant designed to treat opioid addiction, before making a decision on whether to approve the drug, according to Bloomberg News.